DDI Study With Multiple-dose LX4211 and Single Dose Digoxin

NCT02300350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment A digoxin
DRUG: Treatment B LX4211
DRUG: Treatment C Digoxin + 400 mg LX4211 administered concomitantly

Sponsor

Lexicon Pharmaceuticals